Jeffries report, maintains $13 PT. http://www.streetinsider.com/Analyst+Comments/ARIAD+Pharma+%28ARIA%29+Investor+Event+with+Management%3A+Steady+Upside+Likely+to+Continue+-+Jefferies/11666924.html